Business

CHM ceases enrolment in Phase 1 trial and Company update

CHM ceases enrolment in Phase 1 trial and Company update

Chimeric Therapeutics LimitedAugust 18, 20265
CHM ceases enrolment in Phase 1 trial and Company update

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited

More from Chimeric Therapeutics Limited

All Chimeric Therapeutics Limited news →